Forty patients with AD were treated with cholinesterase inhibitors (ChE-Is),evaluated using the MMSE and NPI, and simultaneously sampled to determinetheir serum levels of AChE and BuChE for 180 days. The gene discussed is BCHE; the disease is Alzheimer disease.